Page 72 - GlaxoSmithKline Pharmaceuticals AR 2012

68
Biddle Sawyer Limited
Year
ended 31st
December,
2012
Year
ended 31st
December,
2011
Rs. ’000 Rs. ’000
26 EARNINGS PER SHARE
Earnings per share
Earnings per share is calculated by
dividing the profit attributable to the equity
shareholders by the weighted average
number of equity shares outstanding during
the year. The numbers used in calculating
basic and diluted earnings per equity share
are as stated below:
Profit after taxation (Rs. ‘000) .. .. .. 6,62,15 15,98,33
Weighted average number of shares (Nos.) .. 960000 960000
Earnings per share (Basic and Diluted) - Rs. .. 68.97 166.49
Face value per share - Rs. .. .. .. 10 10
27 CIF VALUE OF IMPORTS
Raw and packing materials .. .. .. 5,65,94 7,13,18
Total 5,65,94 7,13,18
28 VALUE AND PERCENTAGE OF
IMPORTED / INDIGENOUS
MATERIALS CONSUMED
% %
Raw and packing materials
Imported .. .. .. .. 91 4,74,17 89 7,86,07
Indigenous .. .. .. .. 9 48,82 11 96,24
Total 5,22,99 8,82,31
29 RAW AND PACKING MATERIALS
CONSUMED
Alpha D3 .. .. .. .. .. .. 3,65,53 5,18,67
Serratiopeptidase .. .. .. .. .. – 2,74,23
Others .. .. .. .. .. .. .. 109,41 17,83
Packing Material .. .. .. .. .. 48,05 71,58
Total 5,22,99 8,82,31
30 SALES OF TRADED GOODS
Tablets .. .. .. .. .. .. .. 3,39,92 4,16,87
Total 3,39,92 4,16,87
31 PURCHASE OF TRADED GOODS
Tablets .. .. .. .. .. .. .. 35,72 194,82
Total 35,72 194,82
32 SEGMENT REPORTING
The Company has only one segment namely pharmaceuticals; hence no separate
disclosure of segment-wise information has been made.
33 RELATED PARTY DISCLOSURES
1. Related parties with whom there were transactions during the year are listed
below:
Holding Company:
The Company is a wholly owned subsidiary of GlaxoSmithKline Pharmaceuticals
Limited.
2. The following transactions were carried out with the related parties at normal
commercial terms in the ordinary course of business.
Rs. ’000
Holding Company
Year
Ended 31st
December,
2012
Year
Ended 31st
December,
2011
1. Payment of manufacturing charges .. 49,40 52,00
2. Payment of common costs .. .. 77,16 95,71
3. Payment of CSA commission .. .. 84,20 1,55,85
4. Payment of marketing commission .. 2,40,58 4,45,31
5. Dividend payable .. .. .. 22,00,00 18,00,00
6. Outstanding payable/(receivable) by the
Company (net)@ .. .. .. (1,59,05) (1,16,56)
@ Transactions with the above parties are
accounted in the respective current accounts.
34 UNHEDGED FOREIGN CURRENCY EXPOSURE
The foreign currency exposure not hedged as at the year end are as under:
Rs. ’000
Currency Exchange
31st December,
2012
31st December,
2011
USD Euro USD Euro
Net unhedged exposure in currency .. (28,56) 43,51 (3,48,42) –
35 PREVIOUS YEAR FIGURES
The financial statements for the year ended December 31, 2011 had been prepared
as per the then applicable, pre-revised Schedule VI to the Companies Act, 1956.
Consequent to the notification of Revised Schedule VI under the Companies Act,
1956, the financial statements for the year ended December 31, 2012 are prepared
as per Revised Schedule VI. Accordingly, the previous year figures have also
been reclassified to conform to this year’s classification. The adoption of Revised
Schedule VI for previous year figures does not impact recognition and measurement
principles followed for preparation of financial statements.
As per our report of even date attached For and on behalf of the Board
For CORNELIUS & DAVAR Dr. Hasit B. Joshipura M. B. Kapadia
Firm Registration No. 101963W Chairman Director
Chartered Accountants
RUSTOM D. DAVAR
(Partner)
Membership No. F. 10620
Place : Mumbai
Date : 19th February, 2013